Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.75 USD
Change Today -0.04 / -2.23%
Volume 177.8K
AMRS On Other Exchanges
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

amyris inc (AMRS) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/26/14 - $4.50
52 Week Low
06/30/15 - $1.55
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AMYRIS INC (AMRS)

amyris inc (AMRS) Related Businessweek News

No Related Businessweek News Found

amyris inc (AMRS) Details

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. The company applies its industrial synthetic biology platform to design microbes and primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and various materials for performance materials market; renewable fuels for transportation fuels market; and base oils for lubricants market. It has a collaboration partnership with Total to commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

416 Employees
Last Reported Date: 05/7/15
Founded in 2003

amyris inc (AMRS) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $550.0K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $300.0K
President of Research and Development
Total Annual Compensation: $358.8K
Compensation as of Fiscal Year 2014.

amyris inc (AMRS) Key Developments

Amyris, Inc.(NasdaqGS:AMRS) dropped from Russell 2000 Index

Amyris, Inc. will be removed from Russell 2000 Index

Amyris, Inc.(NasdaqGS:AMRS) dropped from Russell 3000 Index

Amyris, Inc. will be removed from the Russell 3000 Index.

Amyris Signs Deal to Distribute Products with Dinaco Importacao Comercio in Brazil

Amyris (AMRS) signed an exclusive deal with Dinaco Importacao Comercio to purchase and re-sell Amyris's Neossance Squalane and Hemisqualane products in the South American nation.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMRS:US $1.75 USD -0.04

AMRS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AJ Greentech Holdings Ltd $0.0060 USD 0.00
American Power Group Corp $0.15 USD +0.0131
China Clean Energy Inc $0.03 USD 0.00
Gevo Inc $3.19 USD -0.07
Solazyme Inc $3.02 USD -0.07
View Industry Companies

Industry Analysis


Industry Average

Valuation AMRS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMYRIS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at